US market: volume extremely low today: 122,000 shares in total, so about $600,000 USD. Not a sell-off by any means - down 9% and up 2% in the AH.
It has been explained to me that the results of this analysis represents an element of "proof" to the FDA - and the KOLs and analysts that manage sophisticated funds: Per the PR: "NfL: The analysis of neurofilament light chain (NfL) levels in spinal fluid is ongoing"
ATH Price at posting:
1.3¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)